Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

NCT00384358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Fractures

Interventions

DRUG: rhBMP-2/CPM
DRUG: rhBMP-2/CPM
OTHER: surgical intervention alone

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer